{"org_id": "T000028936", "org_name_cn": "云南沃森生物技术股份有限公司", "org_short_name_cn": "沃森生物", "org_name_en": "Walvax Biotechnology Co.,Ltd.", "org_short_name_en": "WALVAX", "main_operation_business": "人用疫苗产品研发、生产、销售。", "operating_scope": "　　生物制剂的研究与开发（不含管理商品）；生物项目的引进、合作与开发；生物技术相关项目的技术服务研究与开发；生物制品、生物类药品及相关材料的进出口；技术进出口。（依法须经批准的项目，经相关部门批准后方可开展经营活动）。", "district_encode": "530102", "org_cn_introduction": "云南沃森生物技术股份有限公司是一家专业从事人用疫苗产品研发、生产、销售的生物制药企业，公司主要产品13价肺炎球菌多糖结合疫苗、23价肺炎球菌多糖疫苗、b型流感嗜血杆菌结合疫苗、冻干AC疫苗群脑膜炎球菌多糖结合疫苗、A群C群脑膜炎球菌多糖疫苗、ACYW135群脑膜炎球菌多糖疫苗、吸附无细胞百白破联合疫苗。公司已有多个疫苗产品获批上市，疫苗质量指标达到或高于世界卫生组织规程和《欧洲药典》的规定，在多个关键指标上，公司制定的企业注册标准达到或高于《欧洲药典》的相应规定。", "legal_representative": "李云春", "general_manager": "姜润生", "secretary": "张荔", "established_date": 979574400000, "reg_asset": 1566186984.0, "staff_num": 1481, "telephone": "86-871-68312779", "postcode": "650106", "fax": "86-871-68312779", "email": "ir@walvax.com", "org_website": "www.walvax.com", "reg_address_cn": "云南省昆明市五华区高新开发区北区云南大学科技园2期A3幢4楼", "reg_address_en": "", "office_address_cn": "云南省昆明市五华区高新区科园路99号鼎易天城9栋A座19楼", "office_address_en": "", "currency_encode": "019001", "currency": "CNY", "listed_date": 1289491200000, "provincial_name": "云南省", "actual_controller": "", "classi_name": "民营企业", "pre_name_cn": null, "chairman": "李云春", "executives_nums": 23, "actual_issue_vol": 25000000.0, "issue_price": 95.0, "actual_rc_net_amt": 2221799500.0, "pe_after_issuing": 133.8, "online_success_rate_of_issue": 1.48128453, "affiliate_industry": {"ind_code": "BK0042", "ind_name": "生物制品"}}